cerca CERCA
Venerdì 30 Settembre 2022
Aggiornato: 01:01
Temi caldi

technology platform

comunicato stampa

Zerion Pharma and Hovione extend partnership to cover use of the Dispersome® technology platform in nutraceuticals

LISBON, Portugal, Aug. 23, 2022 /PRNewswire/ -- Hovione and Zerion Pharma A/S (Zerion) today announced an extension of their collaboration on Zerion's Dispersome® technology into the nutraceutical/dietary supplements field. Many dietary supplements suffer from low solubility. This results in poor bioavailability and consequently limits the physiological effect of the supplement. To overcome these limitations, the two companies will collaborate and apply the solubility enhancing Dispersome® techno...

ora in
Prima pagina
in Evidenza